Leadership Overview
Pacira has 4 executives leading key functions including strategy, financial operations, medical affairs, and corporate administration.
Focused on non-opioid pain management, Pacira advances regenerative health solutions to improve patient outcomes globally. This mission drives the organization to create meaningful differences for families and communities through innovative manufacturing and clinical excellence.
Focused on non-opioid pain management, Pacira advances regenerative health solutions to improve patient outcomes globally. This mission drives the organization to create meaningful differences for families and communities through innovative manufacturing and clinical excellence.
Leadership Roles at Pacira
Frank Lee - Chief Executive Officer & Director
Frank Lee, the Chief Executive Officer & Director at Pacira, directs the overarching corporate strategy and long-term vision for non-opioid pain management. Overseeing the entire organizational structure, the Chief Executive Officer & Director ensures alignment between manufacturing capabilities and clinical market needs. This leadership role involves constant engagement with the Board to drive sustainable growth and expand the reach of regenerative health solutions across North American markets. By prioritizing patient outcomes, Frank Lee fosters a culture of innovation that permeates every department. The Chief Executive Officer & Director maintains focus on operational efficiency while scaling the company to meet rising demand for non-opioid alternatives. Through rigorous oversight of executive functions, Lee secures the company's position as a leader in the pharmaceutical sector, ultimately delivering value to patients, families, and shareholders alike.

Shawn Cross - Chief Financial Officer
Shawn Cross, the Chief Financial Officer at Pacira, manages the fiscal health and capital allocation strategies necessary for advancing regenerative health manufacturing. Overseeing global financial planning and analysis, the Chief Financial Officer ensures the company maintains the liquidity required for research and development initiatives. This leadership role involves coordinating with the Board to optimize revenue streams and manage investor relations across international markets. By implementing robust financial controls, Shawn Cross supports the expansion of non-opioid pain management solutions into new clinical territories. The Chief Financial Officer monitors market trends to mitigate risks while identifying opportunities for long-term investment in pharmaceutical infrastructure. Through precise management of corporate assets, Cross strengthens the financial foundation of the organization, enabling the pursuit of patient-centric goals and ensuring the continued viability of the company's diverse product portfolio.

Jonathan Slonin - Chief Medical Officer
Jonathan Slonin, the Chief Medical Officer at Pacira, directs clinical strategy and medical affairs to validate the efficacy of non-opioid pain management solutions. Overseeing the integration of scientific research into clinical practice, the Chief Medical Officer ensures that all regenerative health products meet the highest standards of patient safety and therapeutic performance. This leadership role involves collaborating with healthcare providers to improve clinical outcomes and expand the adoption of non-opioid alternatives in surgical settings. By guiding the medical team through complex regulatory landscapes, Jonathan Slonin facilitates the advancement of innovative treatments that address critical patient needs. The Chief Medical Officer monitors clinical data to refine product applications and support evidence-based medicine across global markets. Through constant focus on medical excellence, Slonin drives the scientific credibility of the company, ensuring that every solution directly benefits patients and improves overall quality of life.
Kristen Williams - Chief Administrative Officer & Corporate Secretary
Kristen Williams, the Chief Administrative Officer & Corporate Secretary at Pacira, manages internal governance and administrative operations to support the company's mission of improving patient outcomes. Overseeing corporate compliance and legal documentation, the Chief Administrative Officer & Corporate Secretary ensures that all organizational activities align with regulatory requirements and ethical standards. This leadership role involves facilitating communication between the Board and executive management to maintain operational transparency. By streamlining administrative processes, Kristen Williams enables the company to focus resources on the development of non-opioid pain management solutions. The Chief Administrative Officer & Corporate Secretary coordinates cross-functional initiatives that enhance organizational efficiency across regional operations. Through diligent management of corporate records and governance frameworks, Williams protects the integrity of the company, ensuring that all internal systems support the broader goal of delivering regenerative health solutions to patients and communities.

Explore Leadership Teams in Manufacturing
Emcure Pharmaceuticals Limited is a global pharmaceutical company engaged in the research, development, manufacturing, and marketing of a broad range of pharmaceutical products and healthcare solutions. Headquartered in Pune, India, the organization operates as an international pharmaceutical enterprise with a strong presence in both domestic and global healthcare markets. The company focuses on delivering innovative and affordable medicines that address a wide spectrum of medical conditions and therapeutic needs across the healthcare sector. The organization is driven by a research-focused strategy that emphasizes innovation, scientific advancement, and the development of effective therapeutic solutions. Through its research and development capabilities, Emcure Pharmaceuticals works to discover and formulate medicines that address unmet medical needs and improve patient outcomes. The company’s research initiatives focus on areas such as complex generics, biosimilars, biologics, and specialized pharmaceutical formulations. These research efforts allow the organization to continuously introduce improved therapies and drug delivery systems designed to enhance treatment effectiveness and patient safety.
Company Leadership SM
TS
RP
VT
Shionogi & Co., Ltd. is a Japanese pharmaceutical company dedicated to developing innovative treatments that improve patient lives worldwide. With a longstanding focus on addressing pressing global health challenges, the company has been a pioneer in discovering and delivering novel therapies for infectious diseases, including antibiotics, HIV, influenza, and emerging viral threats such as COVID-19. Shionogi combines in-house research and development with strategic collaborations across industry, government agencies, biotech companies, and academic institutions to accelerate the advancement of its scientific programs and bring meaningful therapies to patients with urgency and precision.
Company Leadership
TK
DM

Founded in 1993 and located in Cambridge, Massachusetts, Takeda Oncology is the oncology specialty business unit of Takeda Pharmaceutical. Takeda Oncology develops and produces oncology therapies for patients around the world.
Company Leadership CB
RP
TF

Abdi Ibrahim provides pharmaceutical services to the healthcare sector that are beneficial in maintaining people's health. Abdi Ibrahim was founded in 1912 and is based in Istanbul, Turkey.
Company Leadership GO
MÇ
CK